Patent 7157235 was granted and assigned to St Vincent's Hospital, Sydney on January, 2007 by the United States Patent and Trademark Office.
The invention provides methods for diagnosis or prognosis of cardiovascular disease involving the detection of an elevated amount of MIC-1 in a test body sample. The invention also provides methods for treatment of cardiovascular disease and other chronic inflammatory disease.